AT MULTITARGET THERAPEUTICS
Onegene Biotechnology is a company developing transformative therapeutics to
build a better tomorrow for patients with complex and chronic diseases.
With our proprietary protein-protein conjugation technology, UniStac, we develop highly potent tri- or tetraspecific protein-based drug. It allows unlimited combination of different type of molecules, such as Fab fragment, scFv, sdAb, peptide, cytokines, agonist/antagonist, or enzymes. The unprecedented design flexibility with optimized physical properties opens new design space of multispecific protein drug with CMC feasibility.MORE
We are rapidly developing long-acting, multi-target assets that can provide prolonged holistic benefit to treat complex and multifactorial diseases such as NASH, fibrotic diseases and cancers.MORE